F. Crokaert

4.7k total citations · 1 hit paper
81 papers, 3.7k citations indexed

About

F. Crokaert is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, F. Crokaert has authored 81 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 30 papers in Molecular Medicine and 21 papers in Epidemiology. Recurrent topics in F. Crokaert's work include Antibiotic Resistance in Bacteria (30 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Bacterial Identification and Susceptibility Testing (20 papers). F. Crokaert is often cited by papers focused on Antibiotic Resistance in Bacteria (30 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Bacterial Identification and Susceptibility Testing (20 papers). F. Crokaert collaborates with scholars based in Belgium, United Kingdom and Switzerland. F. Crokaert's co-authors include E. Yourassowsky, Dominik Selleslag, J. Ritter, Thomas F. Patterson, John Rex, Ben de Pauw, D Fière, David W. Denning, John E. Bennett and Johan Maertens and has published in prestigious journals such as New England Journal of Medicine, Cancer and Clinical Infectious Diseases.

In The Last Decade

F. Crokaert

78 papers receiving 3.5k citations

Hit Papers

Defining Opportunistic Invasive Fungal Infections in Immu... 2002 2026 2010 2018 2002 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Crokaert Belgium 20 2.2k 2.1k 1.1k 611 357 81 3.7k
Ben de Pauw Netherlands 21 2.5k 1.2× 2.6k 1.3× 1.1k 1.1× 356 0.6× 479 1.3× 41 4.0k
Timothy E. Kiehn United States 39 2.7k 1.2× 2.5k 1.2× 849 0.8× 605 1.0× 326 0.9× 87 4.6k
Michél Laverdière Canada 34 2.9k 1.3× 3.3k 1.6× 592 0.6× 269 0.4× 327 0.9× 103 4.4k
Corrado Girmenia Italy 36 3.0k 1.4× 3.2k 1.6× 1.2k 1.1× 417 0.7× 361 1.0× 138 4.8k
K. V. I. Rolston United States 34 1.5k 0.7× 1.0k 0.5× 1.3k 1.2× 631 1.0× 335 0.9× 86 3.5k
Frank G. Witebsky United States 30 2.5k 1.1× 2.1k 1.0× 773 0.7× 455 0.7× 186 0.5× 70 4.1k
Amar Safdar United States 35 2.5k 1.1× 2.3k 1.1× 818 0.8× 186 0.3× 386 1.1× 86 3.9k
Kenneth Rolston United States 25 1.3k 0.6× 957 0.5× 916 0.9× 649 1.1× 179 0.5× 57 3.0k
Dieter Buchheidt Germany 46 3.4k 1.6× 3.4k 1.7× 1.1k 1.1× 344 0.6× 633 1.8× 134 5.2k
Drew J. Winston United States 48 5.3k 2.5× 3.4k 1.6× 2.5k 2.4× 631 1.0× 451 1.3× 97 8.0k

Countries citing papers authored by F. Crokaert

Since Specialization
Citations

This map shows the geographic impact of F. Crokaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Crokaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Crokaert more than expected).

Fields of papers citing papers by F. Crokaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Crokaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Crokaert. The network helps show where F. Crokaert may publish in the future.

Co-authorship network of co-authors of F. Crokaert

This figure shows the co-authorship network connecting the top 25 collaborators of F. Crokaert. A scholar is included among the top collaborators of F. Crokaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Crokaert. F. Crokaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meuleman, Nathalie, Tatiana Tondreau, Imran Ahmad, et al.. (2009). Infusion of Mesenchymal Stromal Cells can Aid Hematopoietic Recovery Following Allogeneic Hematopoietic Stem Cell Myeloablative Transplant: A Pilot Study. Stem Cells and Development. 18(9). 1247–1252. 70 indexed citations
2.
Viscoli, Claudio, Alain Cometta, Winfried V. Kern, et al.. (2006). Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clinical Microbiology and Infection. 12(3). 212–216. 56 indexed citations
3.
Maaroufi, Younes, et al.. (2006). Development of a multiple internal control for clinical diagnostic real-time amplification assays. FEMS Immunology & Medical Microbiology. 48(2). 183–191. 18 indexed citations
4.
Berghmans, Thierry, F. Crokaert, & Jean‐Paul Sculier. (2002). Vibrio cholerae Bacteremia in a Neutropenic Patient with Non-Small-Cell Lung Carcinoma. European Journal of Clinical Microbiology & Infectious Diseases. 21(9). 676–678. 11 indexed citations
5.
Béguin, Yves, Yves Benoît, F. Crokaert, Dominik Selleslag, & Bernard E. Van Beers. (2002). OUTPATIENT AND HOME PARENTERAL ANTIBIOTIC THERAPY (OHPAT) IN LOW-RISK FEBRILE NEUTROPENIA: CONSENSUS STATEMENT OF A BELGIAN PANEL. Acta Clinica Belgica. 57(6). 309–316. 5 indexed citations
6.
Herbrecht, Raoul, M P Blanc-Vincent, Christine Fuhrmann, et al.. (2000). Standards, Options et Recommandations (SOR) pour la surveillance et la prévention des infections nosocomiales en cancérologie. Bulletin du Cancer. 87(7). 5 indexed citations
7.
Herbrecht, Raoul, M P Blanc-Vincent, Christine Fuhrmann, et al.. (2000). Standards, Options and Recommendations (SOR)for the surveillance and the prevention of cross infections in oncology. Bulletin du Cancer. 87(7). 1 indexed citations
8.
Yourassowsky, E., Mark van der Linden, & F. Crokaert. (1991). Antibacterial Effects of Meropenem and Imipenem against <i>Haemophilus influenzae</i>. Chemotherapy. 37(1). 38–42. 3 indexed citations
9.
Yourassowsky, E., Mark van der Linden, & F. Crokaert. (1990). Antibacterial effect of meropenem and imipenem on Proteus mirabilis. Journal of Antimicrobial Chemotherapy. 26(2). 185–192. 8 indexed citations
10.
Yourassowsky, E., et al.. (1989). Bactericidal activity of LY-163892, a new cephalosporin, against beta-lactamase-producing strains of Haemophilus influenzae compared with amoxicillin-clavulanic acid. Current Therapeutic Research. 45(5). 902–906. 1 indexed citations
11.
Yourassowsky, E., et al.. (1989). Growth Curve Patterns ofEscherichia coli, Serratia marcescens,andProteus vulgarisSubmitted to Different Tigemonam Concentrations. Journal of Chemotherapy. 1(sup2). 49–53. 2 indexed citations
12.
Yourassowsky, E., et al.. (1989). Correlation between the Growth and Killing Curves of <i>Escherichia coli </i>in the Presence of Cefotetan or Piperacillin. Chemotherapy. 35(1). 12–16. 1 indexed citations
13.
Yourassowsky, E., et al.. (1988). Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid againstBranhamella catarrhalis. European Journal of Clinical Microbiology & Infectious Diseases. 7(3). 433–434. 1 indexed citations
14.
Pector, J C, F. Crokaert, F. Lejeune, & A Gérard. (1988). Prolonged survival after resection of a malignant melanoma metastatic to the stomach. Cancer. 61(10). 2134–2135. 11 indexed citations
16.
Yourassowsky, E., et al.. (1987). Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system. European Journal of Clinical Microbiology & Infectious Diseases. 6(6). 634–636. 5 indexed citations
17.
Glupczynski, Y., F. Crokaert, Martial Van der Linden, & E. Yourassowsky. (1985). Activity of cefsulodin against methicillin-resistant Staphylococcus aureus. Current Therapeutic Research. 37(3). 467–471. 1 indexed citations
18.
Yourassowsky, E., et al.. (1982). Growth curve patterns of Escherichia coli and Pseudomonas aeruginosa exposed to different cefsulodin concentrations. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 10(11). 853–854. 1 indexed citations
19.
Yourassowsky, E., et al.. (1982). Antibacterial activity of M.K. 0366 against multiresistant Staphylococcus aureus, Pseudomonas aeruginosa, Enterobacter cloacae, Serratia marcescens and Haemophilus influenzae. Current Therapeutic Research. 32. 36–39. 3 indexed citations
20.
Yourassowsky, E., et al.. (1980). The antimicrobial activity of the cephalosporin CGP 7174/E against Pseudomonas aeruginosa in comparison to carbenicillin, piperacillin and cefotaxime. Current Therapeutic Research. 28(2). 203–207. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026